Treatment of canine hemangiosarcoma with a histone deacetylase inhibitor
AssigneesLeonard A. Cohen, Shantu Amin, Dhimant Desai
InventorsLeonard A. Cohen, Shantu Amin, Dhimant Desai
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a method of treating cancer, particularly canine hemangiosarcoma. The method includes the continuous and regular administration of a formulation including a histone deacetylase inhibitor as part of the standard canine diet. The preferred histone deacetylase inhibitor is SAHA. The formulation is administered following splenectomy to prevent tumor recurrence.
Claims9
A method of treating canine hemangiosarcoma in a canine in need of such treatment, wherein the treatment consists of orally administering to the canine in need thereof an effective amount of a histone deacetylase inhibitor that is a hybrid-polar hydroxamic acid.
Dependencies are inferred from the claim text.